European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI)

The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies. The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published.

European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI) is :-

• International, Peer-Reviewed, Open Access, Refereed, Radiology Nuclear Medicine and imaging, General Medicine, positron emission tomography (PET), single photon emission computed tomography (SPECT), radiochemistry, radiation biology, dosimetry, molecular imaging agents, targeted radionuclide therapy , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1619-7070, E-ISSN: 1619-7089, Established: 1976, Impact Factor: 7.6
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE